NASDAQ:ELDN | Free Cash Flow | Eledon Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2012-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$22.61M
2025-12-31-$14.09M
2025-03-31-$16.06M
2024-12-31-$18.99M
2024-03-31-$8.74M
2023-12-31-$9.13M
2023-03-31-$9.92M
2022-12-31-$9.48M
2022-03-31-$8.16M
2021-12-31-$9.21M
2021-03-31-$5.17M
2020-12-31-$9.43M
2020-03-31-$2.2M
2019-12-31-$2.02M
2019-03-31-$4.02M
2018-12-31-$3.35M
2018-03-31-$2.27M
2017-12-31-$2.61M
2017-03-31-$882,000.00
2016-12-31-$1.28M-$3,000.00-$1.29M
2016-03-31-$9.74M$17,000.00-$9.76M
2015-12-31-$8.88M$216,000.00-$9.09M
2015-03-31-$11.1M$45,000.00-$11.15M
2014-12-31-$6.46M$0.00-$6.46M
2014-03-31-$4.78M$12,000.00-$4.79M
2013-12-31-$6.82M$4,000.00-$6.83M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$62.34M
2024-12-31-$47.27M
2023-12-31-$39.53M
2022-12-31-$28.42M
2021-12-31-$28.91M
2020-12-31-$15.21M
2019-12-31-$13.86M
2018-12-31-$11.89M
2017-12-31-$14.94M
2016-12-31-$4.92M$9,000.00-$4.93M
2015-12-31-$41.24M$565,000.00-$41.8M
2014-12-31-$21.12M$25,000.00-$21.15M
2013-12-31-$15.48M$23,000.00-$15.5M
2012-12-31-$9.33M$8,000.00-$9.34M